Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Kienle

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Haematologica|May 30, 2008
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemiaThorsten Zenz, Sonja Häbe, Axel Benner, et al.
Leukemia & Lymphoma|October 24, 2012
BRAF mutations in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.
Blood|November 30, 2007
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemiaGöran Roos, Alexander Kröber, Pawel Grabowski, et al.
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
Blood|December 3, 2005
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genesDirk Kienle, Axel Benner, Alexander Kröber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanismDaniel Mertens, Stephan Wolf, Cordula Tschuch, et al.
Oncogene|March 6, 2003
Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridizationSwen Wessendorf, Carsten Schwaenen, Holger Kohlhammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemiaAlexander Kröber, Johannes Bloehdorn, Sebastian Hafner, et al.
Haematologica|December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemiaDirk Kienle, Axel Benner, Carolin Läufle, et al.
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Haematologica|May 30, 2008
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemiaThorsten Zenz, Sonja Häbe, Axel Benner, et al.
Leukemia & Lymphoma|October 24, 2012
BRAF mutations in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.
Blood|November 30, 2007
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemiaGöran Roos, Alexander Kröber, Pawel Grabowski, et al.
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
Blood|December 3, 2005
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genesDirk Kienle, Axel Benner, Alexander Kröber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanismDaniel Mertens, Stephan Wolf, Cordula Tschuch, et al.
Oncogene|March 6, 2003
Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridizationSwen Wessendorf, Carsten Schwaenen, Holger Kohlhammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemiaAlexander Kröber, Johannes Bloehdorn, Sebastian Hafner, et al.
Haematologica|December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemiaDirk Kienle, Axel Benner, Carolin Läufle, et al.
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Pageof 2